What is the address of INFIRMIERE JANKOWSKI CHARLOTTE?

The registered office of INFIRMIERE JANKOWSKI CHARLOTTE is located at Rue Germain Michiels(BT) 58, 6500 Beaumont.

Is INFIRMIERE JANKOWSKI CHARLOTTE still active?

Yes. According to the CBE (22 September 2026) INFIRMIERE JANKOWSKI CHARLOTTE is active, legal situation “Normale toestand”, started on 22 October 2019.

Is INFIRMIERE JANKOWSKI CHARLOTTE registered on Peppol?

Yes, INFIRMIERE JANKOWSKI CHARLOTTE is registered on the Peppol network with ID 0208:0736649969.

What is the enterprise number of INFIRMIERE JANKOWSKI CHARLOTTE?

The enterprise number of INFIRMIERE JANKOWSKI CHARLOTTE is BE0736649969.

When was INFIRMIERE JANKOWSKI CHARLOTTE founded?

INFIRMIERE JANKOWSKI CHARLOTTE was founded on 22 October 2019.

Who are the directors of INFIRMIERE JANKOWSKI CHARLOTTE?

According to the 2025 annual accounts, the directors of INFIRMIERE JANKOWSKI CHARLOTTE are: Charlotte Jankowski.

Is INFIRMIERE JANKOWSKI CHARLOTTE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 October 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did INFIRMIERE JANKOWSKI CHARLOTTE make in 2025?

INFIRMIERE JANKOWSKI CHARLOTTE recorded a loss after taxes of € 1,580 in financial year 2025.

What is the revenue of INFIRMIERE JANKOWSKI CHARLOTTE?

As a small company, INFIRMIERE JANKOWSKI CHARLOTTE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 15,211.

INFIRMIERE JANKOWSKI CHARLOTTE (Private Limited)

Dossier INFIRMIERE JANKOWSKI CHARLOTTE, printed on 22 September 2026 from databakkes.be/en/0736649969/infirmiere-jankowski-charlotte. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 7 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

INFIRMIERE JANKOWSKI CHARLOTTE from Beaumont, company number BE0736649969, closed financial year 2025 with a result of € -1,580 after tax. For that financial year INFIRMIERE JANKOWSKI CHARLOTTE recorded a gross margin of € 15,211 and equity of € 3,420. Compared with financial year 2024, the result moved from € 4,583 to € -1,580. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 13, 2026.

What it is worth Healthy

€ 3,420

▼ 32% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -1,580

▼ still € 4,583 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 638

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -1,580.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 32,801

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 34,265

▼ 28% vs 2024

€ 11,888 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 1,842

▼ 6% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,090

▲ 54% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 25,228 Gross margin 2022: € 25,228 First fiscal year in the series	€ 13,032 Gross margin 2023: € 13,032 ▼ 48% vs 2022 (€ 25,228) Unfavourable step	€ 23,167 Gross margin 2024: € 23,167 ▲ 78% vs 2023 (€ 13,032) Favourable step	€ 15,211 Gross margin 2025: € 15,211 ▼ 34% vs 2024 (€ 23,167) Unfavourable step	▼ 34%
Profit after taxes	€ 18,221 Profit after taxes 2022: € 18,221 First fiscal year in the series	€ 6,261 Profit after taxes 2023: € 6,261 ▼ 66% vs 2022 (€ 18,221) Unfavourable step	€ 4,583 Profit after taxes 2024: € 4,583 ▼ 27% vs 2023 (€ 6,261) Unfavourable step	€ -1,580 Profit after taxes 2025: € -1,580 ▼ € 6,163 vs 2024 (€ 4,583) Unfavourable step	▼ € 6,163
Equity	€ 46,851 Equity 2022: € 46,851 First fiscal year in the series	€ 5,000 Equity 2023: € 5,000 ▼ 89% vs 2022 (€ 46,851) Unfavourable step	€ 5,000 Equity 2024: € 5,000 Unchanged (€ 5,000) Unchanged	€ 3,420 Equity 2025: € 3,420 ▼ 32% vs 2024 (€ 5,000) Unfavourable step	▼ 32%
Total debts	€ 13,806 Total debts 2022: € 13,806 First fiscal year in the series	€ 68,446 Total debts 2023: € 68,446 ▲ € 54,641 vs 2022 (€ 13,806) Unfavourable step	€ 52,445 Total debts 2024: € 52,445 ▼ 23% vs 2023 (€ 68,446) Favourable step	€ 40,197 Total debts 2025: € 40,197 ▼ 23% vs 2024 (€ 52,445) Favourable step	▼ 23%
Cash	€ 7,200 Cash 2022: € 7,200 First fiscal year in the series	€ 2,528 Cash 2023: € 2,528 ▼ 65% vs 2022 (€ 7,200) Unfavourable step	-	€ 638 Cash 2025: € 638 First fiscal year in the series
Retained profit	€ 41,851 Retained profit 2022: € 41,851 First fiscal year in the series	€ 0 Retained profit 2023: € 0 ▼ 100% vs 2022 (€ 41,851) Unfavourable step	€ 0 Retained profit 2024: € 0 Unchanged (€ 0) Unchanged	€ -1,580 Retained profit 2025: € -1,580 Unchanged (€ 0) Unfavourable step
Dividend	€ 23,000 Dividend 2022: € 23,000 First fiscal year in the series	€ 48,111 Dividend 2023: € 48,111 ▲ 109% vs 2022 (€ 23,000) Unchanged	€ 4,583 Dividend 2024: € 4,583 ▼ 90% vs 2023 (€ 48,111) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 4,583) Unchanged	▼ 100%
Bank debt	€ 4,396 Bank debt 2022: € 4,396 First fiscal year in the series	€ 61,230 Bank debt 2023: € 61,230 ▲ € 56,834 vs 2022 (€ 4,396) Unfavourable step	€ 47,838 Bank debt 2024: € 47,838 ▼ 22% vs 2023 (€ 61,230) Favourable step	€ 34,265 Bank debt 2025: € 34,265 ▼ 28% vs 2024 (€ 47,838) Favourable step	▼ 28%
Balance sheet total	€ 60,656 Balance sheet total 2022: € 60,656 First fiscal year in the series	€ 73,446 Balance sheet total 2023: € 73,446 ▲ 21% vs 2022 (€ 60,656) Unchanged	€ 57,445 Balance sheet total 2024: € 57,445 ▼ 22% vs 2023 (€ 73,446) Unchanged	€ 43,617 Balance sheet total 2025: € 43,617 ▼ 24% vs 2024 (€ 57,445) Unchanged	▼ 24%

Key figures of INFIRMIERE JANKOWSKI CHARLOTTE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to INFIRMIERE JANKOWSKI CHARLOTTE?

What happened at INFIRMIERE JANKOWSKI CHARLOTTE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 13, 2026 New annual accounts for financial year 2025: loss of € 1,580 (▼ € 6,163 vs 2024). filed late Source: NBB ↗
Oct 22, 2019 New establishment in Beaumont. KBO
Oct 22, 2019 Start of the company according to the CBE. KBO

In short

From € 18,221 profit in 2022 to € 1,580 loss in 2025.

Paid € 13,492 in corporate taxes since 2022.

Best year ever: 2022, with € 18,221 profit.

Paid out € 75,694 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at INFIRMIERE JANKOWSKI CHARLOTTE? We notify you, reason included.

Follow INFIRMIERE JANKOWSKI CHARLOTTE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Charlotte Jankowski

INFIRMIERE JANKOWSKI CHARLOTTE

Behind INFIRMIERE JANKOWSKI CHARLOTTE is Charlotte Jankowski.

See the full network in the app

Directors

According to the 2025 annual accounts

Charlotte Jankowski

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Germain Michiels(BT) 58

6500 Beaumont

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0736.649.969
VAT number: BE 0736.649.969
Registered office: Rue Germain Michiels(BT) 58, 6500 Beaumont
Names & denominations: INFIRMIERE JANKOWSKI CHARLOTTE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 October 2019
Peppol: Active · Active since 4 Aug 2026
Contact: [email protected]

View on CBE Public ↗ Annual accounts (NBB) ↗